

The importance of API particle size on formulation success
On demand webinar recording - now available

Fill the details to view the Webinar


API powder properties and the characterization of an API play a crucial role in drug product development. It impacts the critical quality attributes of drug products such as dissolution, bioavailability, content uniformity, and manufacturability. Designing the right process,equipment, and selecting the appropriate characterization techniques is key to achieve the desired particle size.
The webinar will be complemented by real-world case studies, where we will look at examples of formulation challenges faced by our customers related to API attributes and how our team of experts successfully solved them using right particle engineering approach & state of art infrastructure.
What you will learn:

Application of various particle engineering techniques to tailor API powder properties

The structured problem solving approach in achieving the right particle for your formulation needs

Dr. Reddy's capabilities involved in particle engineering and characterization
Speakers

Srividya Ramakrishnan
Head - Process Engineering, API R&D

Suhas Jawlekar
Process Engineering Expert, API R&D

Amuthan Ramar
Characterisation Expert, Analytical R&D
Summary of the Webinar
In the webinar, experts from Dr. Reddy's - Srividya Ramakrishnan head - process engineering, API R&D, Suhas Jawlekar, process engineering expert, API R&D, and Amuthan Ramar, characterization expert, analytical R&D address the importance of API particle size on formulation success that includes application of various particle engineering techniques and API powder properties, The structured problem-solving approach in achieving the right particle for formulations and Dr. Reddy's capabilities in particle engineering and characterization.
The first section of the webinar covers the relation between pharma API powder properties and drug product attributes – particle size distribution, API formulation, mechanical properties, morphology (drug product attributes), solid form, surface properties, followed by crystal morphology, size, and surface properties.
The next section of the webinar emphasizes particle engineering technologies spectrum, PAT tools to understand crystallization (PVM, FBRM, Raman, FTIR), and particle engineering capabilities – powder processing, API formulation process, control of PSD in slurry and downstream processing.
The concluding section of the webinar showcases the case studies and success stories related to API formulation – Flowability improvement, the outcome of crystallization design, dissolution performances, and case studies on customer requirements regarding the particle size, followed by orthogonal verification for robust and faster PSD methods and image analysis.
Want to learn more about our capabilities in particle engineering and characterization? Then feel free to contact our product experts by filling the form here https://api.drreddys.com/contact-us (Or) at [email protected].
国別の要件がある場合は、お手伝いいたします。
免責事項
このウェブサイト上のいかなる情報も、製品またはサービスへの言及を含め、販売の申し出を構成するものではなく、販売の申し出を表すものと解釈されるものでもありません。有効な特許により保護されている製品は、商用目的で提供または提供されるものではありません。ただし、特定のケースでは、Dr. Reddy の独自の裁量により、現地の法的要件に従って、そのような製品の研究用数量が、規制免除が存在する場所に、インド特許法第 107A 条 (Bolar 免除) に基づく規制提出の目的で提供される場合があります。購入者は、それぞれの市場における特許シナリオを含む製品またはサービスについて独自の評価を行う必要があり、すべての特許関連法的責任を負うことになります。Dr. Reddy は、商品性、特定目的への適合性、および非侵害の保証を含むがこれらに限定されない、明示または黙示を問わずすべての保証を否認します。